Read about our new publication in Blood about the stunning result from our comparative study

In this study we compare patients on warfarin anticoagulation but managed by two different monitoring tests.

Group 1 is monitored by Owren PT but group 2 is is monitored by the new Fiix test.

This resulted in 50 % fewer thrombotic event in the Fiix group